Dr. Grace Farhat is an expert in the role of nutrition, antioxidants, and bioactive components on health, particularly in the context of ageing. With a BSc in Nutrition and Dietetics, an MSc in Human Nutrition, and a PhD focused on the effects of antioxidants on health markers in older adults, she brings a wealth of scientific knowledge to her research.
Her current work explores the impact of pomegranate extract, specifically Pomanox, on inflammatory markers, cardiometabolic health, and cognitive function in older adults. Dr. Farhat’s research provides compelling evidence for the efficacy of pomegranate as a natural intervention for improving health outcomes in ageing populations.
She has authored numerous peer-reviewed publications on the therapeutic effects of pomegranate, polyphenols, and antioxidants in managing chronic conditions such as obesity, inflammation, and cognitive decline. As both a UK Registered Nutritionist (Rnutr) and Registered Dietitian (RD), Dr. Farhat is well-versed in the practical applications of nutrition in addressing health challenges for older adults.
Prof. Eva Serna is a renowned expert in molecular aging, with over two decades of research focused on cellular stress pathways, neurodegeneration, and the role of nutritional bioactives in longevity. She leads the MODULAhR research group at the University of Valencia, specializing in the modulation of the aryl hydrocarbon receptor (AhR)—a transcription factor increasingly recognized as a key regulator of immune function, oxidative balance, and healthy ageing.
Her group has pioneered studies on how dietary compounds like pomegranate extract influence AhR signaling, with promising results in models of ageing-related inflammation, cognitive decline, and neuromuscular deterioration. Prof. Serna’s translational approach bridges molecular biology and nutritional interventions, offering new insights into how natural ingredients can counteract the hallmarks of ageing.
Andrea Zangara holds a BSc in Clinical Psychology from the University of Padua and an MSc in Clinical Phytotherapy from the University of Barcelona. With over 20 years of experience in pharmaceutical and nutraceutical R&D, he has held executive positions in academia and industry. Since 2017, he has led Scientific Marketing & Medical Affairs at Euromed S.A. and currently works as Scientific Communication Advisor.
Ellen Guan has over 15 years of extensive experience in regulatory affairs, covering the entire life cycle of new biologics and chemical drugs. She joined 3DMedicines in 2016 and is currently the Head of Regulatory Affairs department. She led her team to complete the registration work for the global first subcutaneous PD-L1 antibody injection, Envefolimab, in China, as well as seveal IND and pivotal clinical trials in the United States and Japan. She is familiar with the regulations for marketing applications in the Asia-Pacific region and maintains the registration work for post-marketing amendment in China. Before joining 3DMedicines, she worked at BeiGene and was responsible for the global IND filings and approvals of several of BeiGene’s self-developed products.
关怡在药品注册领域拥有超过15年的丰富经验，涵盖生物制品及化学药品新药的全生命周期。2016年加入思路迪医药，目前是该公司药政事务负责人，主持并带领团队完成全球首个皮下注射PD-L1恩沃利单抗注射液的中国上市及美国和日本IND及关键临床的注册工作，熟悉亚太地区的上市申请法规，维护产品在中国上市后变更的注册工作。2016年之前曾就职百济神州，负责数个百济自主研发品种的全球IND申报及批准。
Eric Schnitzer holds a degree in Biochemistry and brings over 16 years of experience in drug development, with a strong focus on eClinical technology. His background spans product strategy, operations, and market expansion, having worked with some of the industry’s leading eClinical providers.Throughout his career, Eric has consistently championed the use of technology to improve trial efficiency and enhance outcomes for all involved. Now at CRScube, he is leading efforts to expand the company’s innovative platform across Europe and the US, helping to streamline clinical trials through unified digital solutions.
Kelly serves as the Sr Director of Data Management Solutions and Services at Vita Global Sciences, bringing nearly three decades of dedicated experience in clinical research – most of that time focused on the intricacies and impact of Data Management. Throughout her career, she has championed innovation, precision, and the highest standards of data quality to help shape meaningful advancements across the life sciences industry.One of the true cornerstones of her professional journey has been mentorship. She is deeply committed to developing future leaders in clinical research, taking pride in cultivating inclusive, high-performing teams that are equipped to tackle the challenges of tomorrow. As she says herself: “Helping others grow isn’t just part of my job – it’s part of my purpose.”Kelly has consistently led the development of scalable data strategies and aligned operational frameworks with clinical objectives to drive measurable outcomes. Whether collaborating across functions or steering complex projects, she strives to create environments where insights thrive and therapeutic breakthroughs become reality.
Sylvain has dedicated his 21-year long carrier on providing software for the pharmaceutical industry. He specialized in clinical trials 16 years ago, working at various eClinical technology vendors. His path has taken him to many conference and webinar stages, where he consistently strives to make the audience think differently about the topic of focus. Sylvain is passionate about implementing solutions that increase the efficiency of all involved in a clinical trial. He is now the Vice President of Strategy and Marketing at CRScube, where he embraces the company’s goal to make clinical trials accessible to everyone. He also dedicates a lot of his time to patient advocacy, increasing awareness about health conditions through his podcast On One Condition.
Alina is a seasoned expert in intelligent automation, with over a decade of experience at ABBYY, a global leader in Intelligent Document Processing. Responsible for identifying and implementing optimal solutions to address customer bottlenecks across Europe, Alina collaborates closely with clients and partners, to drive the adoption of AI technologies and accelerate process automation. Alina holds a Master’s degree in International Economics and is currently pursuing a Master’s in Data Science at University of London, with a focus on the trustworthiness of Generative AI.
Vikki Wang has been with the China office of Maryland Department of Commerce since 2009 and has accumulated many years of experiences in international trade and investment consulting, supporting for Maryland companies’ business interests in China as well as Chinese companies going to Maryland. Past clients span across industries such as medical health, biotech, manufacturing, logistics, agriculture and others.
王艳波女士自2009年加入马里兰州中国办公室至今，拥有多年国际贸易和投资咨询经验，为马里兰州企业在华业务及中国企业赴美投资提供支持，曾服务的客户涉及医疗健康、生物技术、制造业、物流、农业等多个行业。
